Form 4: InnovAge Director Patricia Fontneau Receives Significant RSU Grant

InnovAge Holding Corp. Director Patricia Fontneau was granted 25,316 Restricted Stock Units, aligning her interests with shareholders.

Summary

• Patricia Fontneau, a Director of InnovAge Holding Corp. (INNV), was granted 25,316 Restricted Stock Units (RSUs).
• The transaction date for this grant was July 1, 2025.
• These RSUs will be settled in shares of InnovAge common stock.
• The RSUs are scheduled to vest in full on June 30, 2026.
• Vesting is contingent upon Ms. Fontneau's continued service with InnovAge Holding Corp.
• Following this transaction, Patricia Fontneau beneficially owns 62,125 shares of common stock directly.

Sentiment

Score: 6

Explanation: Slightly positive, as the RSU grant aligns the director's interests with shareholders, which is generally viewed favorably, though it is a routine compensation event.

Positives

• The grant of Restricted Stock Units to a director helps align their long-term interests with those of the company's shareholders.
• Equity compensation is a standard practice for retaining and incentivizing key personnel and board members.

Future Outlook

The granted Restricted Stock Units are set to vest on June 30, 2026, contingent on the director's continued service, indicating a future milestone for this equity compensation.

Industry Context

The grant of Restricted Stock Units to a director is a common practice in the healthcare and broader corporate sectors, serving as a key component of executive and board compensation packages designed to align leadership incentives with long-term shareholder value creation.

Comparison to Industry Standards

• Equity compensation, such as RSU grants, is a standard practice for public company directors across various industries, including healthcare, to foster long-term alignment with shareholder interests.
• The structure of vesting contingent on continued service is typical for such grants, similar to practices observed at comparable healthcare providers or managed care organizations.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the long-term performance of the company's stock, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• The Restricted Stock Units are expected to vest on June 30, 2026, subject to Patricia Fontneau's continued service with InnovAge Holding Corp.

Key Dates

Keywords

InnovAge Holding Corp., INNV, Restricted Stock Units, RSU, Equity Compensation, Director Compensation, Insider Transaction, Corporate Governance